Kala Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	50.9	70.5	94.18	77.26	85.45	183.1	114.7	45.58	5.87
Short-Term Investments	0	0	0	76.28	0	0	0	0	0
Cash & Cash Equivalents	50.9	70.5	94.18	153.54	85.45	183.1	114.7	45.58	5.87
Cash Growth	-27.80%	-25.15%	-38.66%	79.69%	-53.33%	59.64%	151.64%	676.77%	-
Receivables	0	0	15.35	9.6	11.56	0	0	0	0
Inventory	0	0	18.22	11.45	8.43	4.1	0	0	0
Other Current Assets	1.98	15.45	-3.37	-3.21	0.05	-10.17	0.51	0.05	1.73
Total Current Assets	52.87	85.94	124.37	171.38	105.48	177.03	115.21	45.63	7.6
Property, Plant & Equipment	2.78	0.42	4.02	31.02	32.48	31.73	1.2	0.59	0.74
Long-Term Investments	0.3	0.46	1.46	12.99	12.58	0	0	0	0
Other Long-Term Assets	0	0	9.58	6.22	3.78	12.21	0.13	0.11	0.11
Total Long-Term Assets	3.08	0.88	15.06	50.23	48.84	43.94	1.33	0.7	0.85
Total Assets	55.95	86.82	139.43	221.61	154.32	220.97	116.55	46.33	8.45
Accounts Payable	0.92	2.83	4.9	1.72	2.52	5.45	1.2	1	1.4
Deferred Revenue	1.08	0	0	0	0	0	0	0	0
Current Debt	0.33	5.01	0.71	1.53	1.33	0.46	6.67	0.56	2
Other Current Liabilities	6.02	17.84	31.81	18.97	20.93	11.1	7	3.99	2.1
Total Current Liabilities	8.35	25.69	37.42	22.23	24.77	17.01	14.87	5.55	5.51
Long-Term Debt	35.99	37.94	79.48	99.39	99.86	98.98	11.99	9.1	7.8
Other Long-Term Liabilities	4.11	4.22	5.72	0	0	0	0.01	1.06	0.94
Total Long-Term Liabilities	40.1	42.16	85.2	99.39	99.86	98.98	12	10.15	8.73
Total Liabilities	48.45	67.85	122.62	121.61	124.63	115.99	26.87	15.7	14.24
Total Debt	36.32	42.95	80.19	100.92	101.18	99.44	18.65	9.65	9.8
Debt Growth	-15.43%	-46.44%	-20.54%	-0.26%	1.75%	433.08%	93.23%	-1.44%	-
Retained Earnings	-629.41	-587.21	-542.39	-399.78	-295.46	-201.11	-134.37	-92.14	-58.97
Comprehensive Income	0	0	0	0	0	0	0	0	0
Shareholders' Equity	7.5	18.97	16.8	100	29.69	104.98	89.68	-87.76	-56.66
Net Cash / Debt	14.57	27.55	13.99	52.62	-15.74	83.66	96.05	35.93	-3.93
Net Cash / Debt Growth	-47.10%	96.89%	-73.42%	-	-	-12.89%	167.33%	-	-
Net Cash Per Share	5.99	18.11	10.63	50.24	-23.00	156.36	422.18	1520.46	-175.27
Working Capital	44.52	60.26	86.94	149.15	80.71	160.02	100.34	40.08	2.09
Book Value Per Share	3.09	12.48	12.76	95.46	43.40	196.19	394.19	-3714.23	-2529.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).